Terns Pharmaceuticals, Inc. (TERN)
42.56
+2.33
(+5.79%)
USD |
NASDAQ |
Dec 09, 16:00
43.08
+0.52
(+1.22%)
After-Hours: 20:00
Terns Pharmaceuticals EPS Diluted (Quarterly): -0.2686 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Altimmune, Inc. | -0.2126 |
| Viking Therapeutics, Inc. | -0.8083 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.64M |
| Total Expenses (Quarterly) | 24.64M |
| Enterprise Value | 3.329B |
| Earnings Yield | -2.42% |
| Normalized Earnings Yield | -2.425 |